Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$251K Buy
2,672
+129
+5% +$12.9K ﹤0.01% 601
2025
Q4
$251K Buy
+2,543
New +$246K ﹤0.01% 607
2017
Q1
Sell
-17,197
Closed -$1.72M 497
2016
Q4
$1.72M Sell
17,197
-8,350
-33% -$815K 0.01% 384
2016
Q3
$2.41M Sell
25,547
-3,962
-13% -$334K 0.02% 291
2016
Q2
$2.36M Buy
29,509
+15,319
+108% +$1.19M 0.02% 294
2016
Q1
$1.03M Sell
14,190
-14,099
-50% -$1.05M 0.01% 469
2015
Q4
$3.07M Sell
28,289
-4,148
-13% -$463K 0.02% 274
2015
Q3
$3.58M Sell
32,437
-23,422
-42% -$2.63M 0.03% 226
2015
Q2
$5.82M Buy
55,859
+2,797
+5% +$290K 0.04% 214
2015
Q1
$4.86M Buy
+53,062
New +$4.39M 0.02% 395

Other funds holding INCY

TCW Group's INCY Position: Q1 2026 in Review

TCW Group increased its Incyte (INCY) stake by 5.1% in Q1 2026, buying an estimated $12.9K and bringing the position to 2,672 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #601.

TCW Group first reported a position in INCY in Q1 2015 and has held it in 10 quarters since. The position peaked at $5.82M in Q2 2015. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • TCW Group held 2,672 shares of Incyte worth $251K as of Q1 2026.
  • TCW Group bought 129 Incyte shares in Q1 2026, an estimated $12.9K.
  • Incyte made up ﹤0.01% of TCW Group's portfolio in Q1 2026, its #601 holding.
  • TCW Group first reported a position in Incyte in Q1 2015 and has held it in 10 quarters since.
  • TCW Group's Incyte position peaked at $5.82M in Q2 2015.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.